ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Adult Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,151Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 56

$1.85M Total Retail Price of All Prescriptions

Rank: 1 out of 56

979 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 979 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

20% of this provider’s 979 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 23,744 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 31%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
HYDROCODONE-ACETAMINOPHEN 1,060 742 S3 1 12
LEVOTHYROXINE SODIUM 1,019 965 2 4
OMEPRAZOLE 895 733 3 3
LISINOPRIL 770 633 4 5
METOPROLOL TARTRATE 698 590 5 6
WARFARIN SODIUM 675 570 6 14
FUROSEMIDE 649 570 7 7
AMLODIPINE BESYLATE 540 475 8 2
DONEPEZIL HCL 520 496 9 34
GABAPENTIN 481 403 10 22
SIMVASTATIN 459 397 11 1
BUMETANIDE 417 397 12 55
ISOSORBIDE MONONITRATE ER 385 362 13 33
ATORVASTATIN CALCIUM 384 335 14 11
POTASSIUM CHLORIDE 371 333 15 20
METFORMIN HCL 348 282 16 8
CITALOPRAM HBR 341 293 17 37
CARVEDILOL 341 336 17 25
ATENOLOL 324 303 19 13
FAMOTIDINE 300 237 20 53
NAMENDA 289 286 21 42
MIRTAZAPINE 253 236 22 48
KLOR-CON M20 250 227 23 58
RISPERIDONE 242 225 24 69
CYMBALTA 237 207 25 52
NOVOLOG 213 188 26 71
DIGOXIN 208 190 27 44
HUMALOG 206 157 28 97
ESCITALOPRAM OXALATE 205 172 29 54
BISOPROLOL-HYDROCHLOROTHIAZIDE 204 188 30 100
LANTUS 203 158 31 78
HYDRALAZINE HCL 193 173 32 64
LEVETIRACETAM 191 155 33 60
LOSARTAN POTASSIUM 188 174 34 17
SODIUM CHLORIDE 186 172 35 103
CLOPIDOGREL 186 158 35 23
PRAVASTATIN SODIUM 181 156 37 27
CRESTOR 180 147 38 15
CARBIDOPA-LEVODOPA 177 164 39 82
PREDNISONE 175 147 40 88
ZOLPIDEM TARTRATE 175 171 40 16
ALLOPURINOL 171 152 42 51
METOPROLOL SUCCINATE 164 146 43 9
KLOR-CON M10 159 152 44 110
AZITHROMYCIN 157 106 45 31
QUETIAPINE FUMARATE 157 136 45 59
CIPROFLOXACIN HCL 150 110 47 101
CLONIDINE HCL 146 98 48 66
HYDROCHLOROTHIAZIDE 144 127 49 10
DIOVAN 142 139 50 21
PLAVIX 138 128 51 28
NIASPAN 137 104 52 62
TRAZODONE HCL 137 79 52 102
INSULIN SYRINGE 137 109 52 117
ALENDRONATE SODIUM 133 107 55 18
CEPHALEXIN 128 95 56 121
RAMIPRIL 127 116 57 32
TAMSULOSIN HCL 126 114 58 26
RANITIDINE HCL 123 115 59 36
BACLOFEN 121 75 60 71
SULFAMETHOXAZOLE-TRIMETHOPRIM 120 111 61 126
PANTOPRAZOLE SODIUM 118 84 62 75
LOVASTATIN 113 112 63 43
GLIPIZIDE 110 95 64 109
NOVOLOG MIX 70-30 109 106 65 134
GLIMEPIRIDE 107 81 66 40
NYSTOP 106 77 67 137
NEXIUM 104 66 68 19
LABETALOL HCL 104 96 68 138
FLUTICASONE PROPIONATE 103 76 70 50
SANTYL 100 93 71 112
POLYETHYLENE GLYCOL 3350 99 92 72 49
DOXAZOSIN MESYLATE 98 88 73 83
LYRICA 95 49 74 92
TRIAMCINOLONE ACETONIDE 95 88 74 140
IPRATROPIUM-ALBUTEROL 94 87 76 141
VENLAFAXINE HCL ER 92 92 77 142
FENTANYL 91 82 S2 78 98
OXYBUTYNIN CHLORIDE ER 91 78 78 145
FINASTERIDE 90 78 80 91
SYMBICORT 90 72 80 85
VANCOMYCIN HCL 89 75 82 146
SERTRALINE HCL 88 81 83 38
DIVALPROEX SODIUM 87 62 84 95
NYSTATIN 87 79 84 105
HYDROXYZINE HCL 87 66 R 84 147
METOCLOPRAMIDE HCL 87 62 84 107
AGGRENOX 86 70 88 148
SPIRONOLACTONE 86 63 88 67
PROAIR HFA 86 52 88 45
OXCARBAZEPINE 82 81 91 149
HYDROCORTISONE 82 78 91 149
TRAMADOL HCL 81 45 93 29
LATANOPROST 79 79 94 155
DETROL LA 79 79 94 155
NOVOLIN 70-30 79 79 94 155
COMBIVENT 78 56 97 158
LEXAPRO 77 70 98 159
SYNTHROID 76 76 99 30
PHENYTOIN SODIUM EXTENDED 75 38 100 123
OLANZAPINE 74 66 101 160
VENTOLIN HFA 73 47 102 87
ADVAIR DISKUS 73 61 102 35
TORSEMIDE 73 72 102 118
JANUVIA 71 64 105 41
AMOX TR-POTASSIUM CLAVULANATE 70 57 106 164
HALOPERIDOL 68 57 107 166
CARISOPRODOL 67 0 R 108 85
METHYLPREDNISOLONE 67 44 108 170
SEROQUEL 67 61 108 170
BISOPROLOL FUMARATE 64 62 111 175
MEGESTROL ACETATE 63 55 R 112 176
OLANZAPINE ODT 61 61 113 177
OXYCODONE-ACETAMINOPHEN 61 54 S2 113 125
QUINAPRIL HCL 60 47 115 79
LANTUS SOLOSTAR 59 40 116 114
TAMIFLU 58 53 117 182
LACTULOSE 58 41 117 77
DILTIAZEM 24HR ER 58 47 117 81
LIDOCAINE 57 32 120 185
DILTIAZEM HCL 57 49 120 185
AMLODIPINE BESYLATE-BENAZEPRIL 56 39 122 71
PEN NEEDLE 54 44 123 192
PRAMIPEXOLE DIHYDROCHLORIDE 50 50 124 197
TRIHEXYPHENIDYL HCL 50 48 R 124 197
SPIRIVA 50 40 124 47
NIFEDIPINE ER 50 50 124 120
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 12, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.